data recent publish sale valu india
y/i march compar februari januari
see figur look data stack basi
india pharma growth march compar
februari januari respect comparison
broader indian pharma market grew y/i march vs
februari januari see figur
stack basi broader indian pharma market growth
march compar februari
januari respect increas price target
base ep estim
aggreg aiocd data january-march suggest india
pharma growth y/i compar broader
india pharma market growth y/i stack
basi india pharma growth vs
recal report overal epd growth ex-fx
sequenti acceler compar ex-fx
guid epd growth mid-singl high-single-
digit earn call pre-coronaviru model epd
revenu ex-fx report y/i growth
india account overal epd sale
believ aiocd data provid level visibl
aiocd data suggest compar februari seem
modestli acceler overal market deceler
would note indian govern announc day
countrywid lockdown march essenti
servic oper hospit relat medic
includ dispensari chemist medic
equip shop exempt lockdown march data would
repres one week nation lockdown addit
coronaviru pandem develop understand
impact india pharmaceut busi april
data per john hopkin univers tracker india
confirm case
pleas see page rate definit import disclosur
requir analyst certif estimates/forecast
well fargo secur llc seek busi compani
cover research report result investor awar
firm may conflict interest could affect object report
investor consid report singl factor make
compani data secur llc estim reuter
ep exclud amort intang ep continu
oper ep includ stj amo alr deal
compani data secur llc estim reuter
note monthli valu crore indian rupe repres wholesal retail channel valu includ
bonus/promot product provid manufactur bonus/promot valu histor repres
total valu inr rupe cr crore ten million
note monthli valu crore indian rupe repres wholesal retail channel valu includ
bonus/promot product provid manufactur bonus/promot valu histor repres
total valu inr rupe cr crore ten million
price target
price target base ep estim risk target includ
slower growth key busi market delay stj alr integr slower margin
expect continu deliv double-digit underli ep growth mid high-singl digit
underli sale growth oper leverag
abbott laboratori diversifi global medic product compani four key busi segment
nutrit diagnost establish pharmaceut epd medic devic compani report
total revenu compani acquir stj januari nearli doubl
